The estimated Net Worth of Denise M Morrison is at least $6.6 Milion dollars as of 6 August 2019. Ms. Morrison owns over 1,000 units of Quest Diagnostics stock worth over $494,924 and over the last 21 years she sold DGX stock worth over $5,798,753. In addition, she makes $308,654 as Independent Director at Quest Diagnostics.
Denise has made over 7 trades of the Quest Diagnostics stock since 2005, according to the Form 4 filled with the SEC. Most recently she bought 1,000 units of DGX stock worth $171,130 on 6 August 2019.
The largest trade she's ever made was exercising 127,000 units of Quest Diagnostics stock on 5 September 2012 worth over $3,100,070. On average, Denise trades about 2,535 units every 47 days since 2003. As of 6 August 2019 she still owns at least 3,223 units of Quest Diagnostics stock.
You can see the complete history of Ms. Morrison stock trades at the bottom of the page.
Denise M. Morrison serves as Independent Director of the Company. Ms. Morrison is the founder of Denise Morrison & Associates, LLC, a consulting firm. She retired in 2018 as the President and Chief Executive Officer of Campbell Soup Company. Ms. Morrison joined Campbell in 2003, where she held positions of increasing responsibility. Prior to joining Campbell, she held executive management positions at Kraft Foods, Inc. from 2001 to 2003. Ms. Morrison is a director of Visa, Inc. and MetLife, Inc., and served as a director of Campbell Soup Company from 2010 to 2018 and a director of The Goodyear Tire & Rubber Company from 2005 to 2010. She is a member of the Board of Trustees for Boston College, the Advisory Counsel for Just Capital, and the Advisory Board for Tufts Friedman School of Nutrition Science and Policy and is a member of The Business Council. Ms. Morrison served on President Trump’s Manufacturing Jobs Initiative as well as President Obama’s Export Council.
As the Independent Director of Quest Diagnostics, the total compensation of Denise Morrison at Quest Diagnostics is $308,654. There are 12 executives at Quest Diagnostics getting paid more, with Stephen Rusckowski having the highest compensation of $10,118,500.
Denise Morrison is 66, she's been the Independent Director of Quest Diagnostics since 2019. There are 3 older and 18 younger executives at Quest Diagnostics. The oldest executive at Quest Diagnostics, Inc. is Gail Wilensky, 76, who is the Independent Director.
Denise's mailing address filed with the SEC is METLIFE, INC., 200 PARK AVENUE, NEW YORK, NY, 10166.
Over the last 21 years, insiders at Quest Diagnostics have traded over $67,426,608 worth of Quest Diagnostics stock and bought 34,000 units worth $1,910,090 . The most active insiders traders include Plc Gsk, James F Iii Flaherty oraz Jeffrey M Leiden. On average, Quest Diagnostics executives and independent directors trade stock every 19 days with the average trade being worth of $3,750,703. The most recent stock trade was executed by Michael E Prevoznik on 29 August 2024, trading 32,551 units of DGX stock currently worth $3,118,386.
quest diagnostics (nyse: dgx) empowers people to take action to improve health outcomes. derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. quest annually serves one in three adult americans and half the physicians and hospitals in the united states, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. the company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (ap) services, & interpretive consultation through its medical & scientific staff of about 900 m.d.s & ph.d.s. the company reported 2014 revenues of $7.4 billion. quest diagnostics offers the most extensive clinical testing network in the u.s., with laborator
Quest Diagnostics executives and other stock owners filed with the SEC include: